|
Could this
mean an end to Cataract Surgery?
A revolutionary new treatment for cataracts has been gaining in
popularity here in Europe since it was featured over in the UK on the
Richard & Judy Television Show last year with amazing results. Ethos
GmbH Schweiz, the Swiss manufacturers, claim 'This could mean an end to
cataract surgery'. The product, called Ethos Endymion "Bright Eyes",
uses a special derivative of the naturally occurring neuropeptide
L-Carnosine, called N-Acetyl-Carnosine (NAC), which is a super
antioxidant and anti-glycating agent. NAC, when topically applied, can
penetrate and protect the lipid tissues of the eye against light damage
and also helps to diminish free radical damage and the harmful effects
of glycosylation associated with degenerative eye disease.
Cataract is a major problem globally;
17 million people around the world are blind because of cataracts
and 28,000 new cases are reported every day. Approximately 25% of the
population over 65 (and about 50% over 80) have a serious loss of vision
due to cataracts. At any one time in the UK alone there are over 500,000
people awaiting cataract surgery and the figures for the rest of Europe
are frightening. One leading London Hospital over in the UK carries out
between 250 and 500 cataract operations a week! The backlog is proving
to be such a big problem for them that now, Cataract Units are being
drafted in from abroad to help to address their very worrying situation.
Professor Steven Charles Gallant, the world renowned biochemist who was
originally responsible for introducing Bright Eyes to Europe says; "I
have been studying the effects of L-Carnosine for many years. It was
first discovered back in 1988 that N-Acetyl-Carnosine had positive
effects on cataracts. My father had cataracts and did not relish going
under the knife so I tried to get some for him but unfortunately, at the
time, it wasn't easily obtainable. My father had to have the operation,
which thankfully was successful. But that got me to thinking how great
it would be if we were to develop, and make readily available, a product
whereby this condition could be addressed with a simple course of eye
drops as opposed to invasive surgery. After many years' research,
development and trials of Bright Eyes, many people are now enjoying
much-improved vision due to this exciting medical breakthrough."
One of the clinical trials carried out in China, on 96 patients with
cataracts of varying degrees of severity, showed a profound effect; with
the effective rate being 100% on primary senile cataract and 80% for
mature senile cataract over the 6 month trial period. Positive
effects were also observed with other types of cataract. Another trial
indicated an eye condition improvement of 41.5% to 100% for patients
within a 6-month period, with sustainable results 24-months later.
A box of Bright Eyes costs 100 Swiss francs (approximately £50, €75 or
$100) and contains 5 x 2ml vials which is roughly a month's supply when
using two drops a day in each eye. With the majority of people seeing
positive results over a 3-6 month period, it is a relatively inexpensive
course of treatment when you consider that a cataract operation costs
over 4,000 Swiss francs (approximately £2,000, €3,000 or $3,500) for one
eye, and over 7,500 Swiss francs (approximately £3,500, €5,000 or
$6,500) for both.

|